BM

Brad Meikle

Private equity firms

2 min read · 14 July 2014

Portfolio companies

2 min read · 14 July 2014

Service providers

2 min read · 14 July 2014

Promotions

1 min read · 14 July 2014

Oxygen flows freely to sub-$1 billion funds

At the peak of the last fundraising boom six years ago, sponsors had reason to feel like small potatoes if they were targeting anything less than $1 billion. Today, with fundraising soaring again, such firms are playing a far larger role in the market.

7 min read · 14 July 2014

JOBS Act update: what sponsors need to know

Readers of Buyouts are familiar with the JOBS Act, which, among other things, lifted the ban against general solicitation for certain exempt offerings and will, once the U.S. Securities and Exchange Commission approves regulations, permit non-accredited investors to make investments into exempt offerings through crowdfunding “portals.”

3 min read · 14 July 2014

Texas County & District Retirement off to sizzling commitment pace in 2014

The Texas County & District Retirement System will likely slow the pace of its commitments to private equity during the second half of 2014 after a gusher of pledges in the first half, Investment Officer Paul Williams wrote to Buyouts in an email.

2 min read · 11 July 2014

PCP becomes Diagnos minority investor at close of Warnex merger

Canadian healthcare-focused private equity firm Persistence Capital Partners (PCP) has become a minority shareholder in Diagnos Inc (TSXV: ADK) following the completion of Diagnos' merger with Warnex Inc, a PCP portfolio company. PCP has assumed a 13.76 percent interest in Diagnos, which is a Brossard, Québec-based provider of data mining and consulting services and a designer of data analytics software for healthcare and natural resources industries. PCP also holds warrants to purchase common shares of the company. Based in Montréal, PCP is currently raising its second fund, Persistence Capital Partners II LP.

2 min read · 11 July 2014

Difference Capital, Benev feud over $103 mln royalties deal

Canadian specialty finance firm Difference Capital Financial has objected to an announcement by portfolio company Benev Capital Inc (TSX-V: BEV) that it will buy royalties from Franworks Franchise Corp for about $103 million. Difference Capital said the announcement did not reflect the unanimous recommendation of the board of directors, as directors did not include its nominees. The firm also said it is "skeptical as to the fairness of the process" that led to the transaction. Benev has responded, saying the deal was finalized before recent board changes, was properly processed, and enjoys the support of other shareholders.

3 min read · 11 July 2014

Spectrum Equity raises new $1 bln fund

Private equity firm Spectrum Equity said it had raised $1 billion for its seventh fund focused on investments in information technology services.

1 min read · 11 July 2014

Showing 1,911 to 1,920 of 52,100 results
1…191193…1000